Experic, a Cranbury, NJ-based contract development and manufacturing organization (CDMO) and clinical trial supply services company, received a growth investment of an undisclosed amount.
Backers included 1315 Capital, East Seattle Partners, Harro Höfliger Packaging Systems, and Kineticos Ventures.
The company intends to use the funds to further enhance its manufacturing capabilities, accelerate its international expansion plans, and support its mission to deliver high-quality, agile services to the biopharmaceutical sector.
Led by CEO David Wood, Experic is a contract development and manufacturing organization (CDMO) and clinical trial supply services company specializing in development and manufacturing services for biopharmaceutical and pharmaceutical companies. The company offers a comprehensive suite of services designed to accelerate the development and commercialization of innovative therapies across a range of packaging and finished dose modalities, including dry powder inhalation (DPI) products. Leveraging its cGMP facility, Experic manages global delivery of products and services, even for expedited projects, while providing knowledge, expertise, and customer service.
FinSMEs
30/10/2024